Interestingly, patients with surgically removed GBM treated with temozolomide showed a longer overall survival if the resected tumor had low levels of mGlu3 transcript, and the methylation state of the MGMT gene promoter influenced survival only in patients with low mGlu3 receptor mRNA in the tumor [29]. This evidence concerns the gene GRM3 and glioblastoma.